We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Fresenius SE & Co KGaA (FRE) NPV

Sell:€34.56 Buy:€34.86 Change: €0.03 (0.09%)
Market closed |  Prices as at close on 14 January 2025 | Switch to live prices |
Sell:€34.56
Buy:€34.86
Change: €0.03 (0.09%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 14 January 2025 | Switch to live prices |
Sell:€34.56
Buy:€34.86
Change: €0.03 (0.09%)
Market closed |  Prices as at close on 14 January 2025 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Fresenius SE & Co KGaA is a Germany-based healthcare company. The Company has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.

Contact details

Address:
Else-Kroener-Str. 1
BAD HOMBURG
61352
Germany
Telephone:
+49 (6172) 6080
Website:
https://www.fresenius.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
FRE
ISIN:
DE0005785604
Market cap:
€19.45 billion
Shares in issue:
563.24 million
Sector:
Health Care Services
Exchange:
Frankfurt Stock Exchange
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • Wolfgang Kirsch
    Independent Chairman of the Supervisory Board
  • Michael Sen
    Chairman of the Management Board
  • Michael Diekmann
    Independent Deputy Chairman of the Supervisory Board
  • Grit Genster
    Independent Deputy Chairman of the Supervisory Board
  • Sara Hennicken
    Chief Financial Officer, Member of the Management Board
  • Pierluigi Antonelli
    Member of the Management Board, Chief Executive Officer - Fresenius Kabi
  • Robert Moeller
    Member of the Management Board, Chief Executive Officer of Business Segment Fresenius Helios
  • Michael Moser
    Member of the Management Board, Responsible for Legal, Compliance, Risk Management, ESG, Human Resources and Fresenius Vamed

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.